Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
CFDA Overhauls Drug Registration Regime as Healthcare Reforms Stumbles Forward
Chief Editor James Shen offers his regular monthly review of the Chinese healthcare sector with this issue's emphasis on CFDA's proposed new regulation for drug registrat... (7/29/2016)
   
China to Grow Big on e-Healthcare Data (8/25/2016)
Anhui Model: Will It Be the Future of China's Health Care Provider Payment Reform? (Part 1) (8/25/2016)
Asia's Pharma Investment Shows the Benefit of Patent Protection (8/25/2016)
Building A Better Government Affairs Function In China (8/25/2016)
China's New Regulation On Health Care And Medical Big Data Might Unlock Online Sales Of Prescription Drugs (8/25/2016)
Cutting Through the Red Tape: CFDA Plans to Accelerate the Review Process for Medical Devices (8/10/2016)
The View of China from Headquarters (8/2/2016)
China Solicits Comments on Drug Registration Rules (8/2/2016)
CFDA Overhauls Drug Registration Regime as Healthcare Reforms Stumbles Forward (7/29/2016)
Chinese Government Determined to Strengthen Patent Protection (7/28/2016)
New Judicial Interpretation On Patent Infringement (7/28/2016)
Foreign Businesses Should Be Concerned by China's Proposed New IP Competition Rules, But Hopeful Too (7/27/2016)
White Paper: The Future of Pharmaceutical Marketing in China (7/27/2016)
Facing Cancer Drug Shortage, US Relies on Banned Chinese Plant (7/25/2016)
NHFPC Releases 2015 Annual Health and Family Planning Sector Development Report (Full Summary) (7/24/2016)
21 Chinese Hospitals to Adopt Watson for...  (8/25/2016) (free)
BioLineRx, Chinese VC Form Pharma R&...  (8/25/2016) (free)
China's BGI Invests in Australian Genomi...  (8/25/2016)
Chinese Leadership Highlights the Way Fo...  (8/25/2016)
Former Chinese Pharma Executive Settles ...  (8/25/2016)
Luye Medical Enters Strategic Alliance M...  (8/19/2016)
Histogen Receives $6 Mln Investment From...  (8/19/2016)
Upcoming Event: Pharma Business Developm...  (8/19/2016) (free)
CFDA Seeks Comments on GLP Amendment  (8/19/2016)
SMEI: Chinese Urban and County Level Pub...  (8/19/2016)
SMEI: Chinese Online Pharmacy Drug Sales...  (8/19/2016)
BeiGene Approved for Clinical Trials in ...  (8/18/2016) (free)
CFDA Issues Dossier Requirements for Qua...  (8/18/2016)
CPIIC: Hospital Drug Sales Growth Reboun...  (8/17/2016)
Retail Sales of Topical Analgesics in Fi...  (8/17/2016)
Top Three TCs Account for 68% of Overall Global Pharma I...
Sanofi, Boehringer Ingelheim Agree to Swap Business Asse...
Novartis Splits Pharmaceuticals Division Into Two Busine...
IMS Health Holdings and Quintiles to Combine
Pfizer Abandons Plans to Take Over Allergan Citing New U...
SMEI: Chinese Urban and County Level Public Hospital Drug Marke...
SMEI: Chinese Online Pharmacy Drug Sales Up 52.4% in 2015
CPIIC: Hospital Drug Sales Growth Rebounded in Q1/2016
Retail Sales of Topical Analgesics in Five Major Chinese Cities...
Chinese Pharma Formulation Export Fell 1.2% in the First Half a...
BioLineRx, Chinese VC Form Pharma R&D JV in China
China's BGI Invests in Australian Genomics R&D
Luye Medical Enters Strategic Alliance MOU with Chongqing Mu...
Histogen Receives $6 Mln Investment From Huapont for Hair Gr...
SATCM Issues 13th FYP for TCM Industry Development
CFDA Seeks Comments on GLP Amendment
CFDA Issues Dossier Requirements for Quality and Efficac...
CFDA Releases Summary of Drug Approvals Subject To Quali...
CFDA to Complete Legal Framework for Food and Drug Regul...
CFDA Approved 31 Drug Applications in July
The SPP Issues Notice for Occupational Crimes in Food and Dr...
NDRC Fines Three Domestic Pharma Cos CNY 2.6M for Price Mono...
China's Supreme Court Sides with Local Company in Eli Lilly ...
State Council Introduces New Guidelines for Fair Competition...
China Leads Global Pharma Innovation? By Number of Patent Ap...
Frontage, Zhejiang Jiuzhou Form CDMO JV for NCE and API ...
Chinese API Industry Revenue Expected to Grow at 9.5% GA...
UK Regenerative Medicine Supplier Expands to China Thru ...
FDA Issues More Warnings Against Chinese API Producers
Dong-A ST Signs Exclusive Deal with Suzhou Sino for Teri...
BeiGene Approved for Clinical Trials in China with PARP ...
CFDA Accepts Eisai's NDA for Anticancer Halaven
Immunicum to be Granted Chinese Patent for Anticancer CD...
Chinese Scientists to Embark on First Human Trial with C...
Domestic HPV Vaccine in Final Stage of Clinical Trial
21 Chinese Hospitals to Adopt Watson for Oncology for Ca...
Chinese Leadership Highlights the Way Forward for Health...
China Faces Epidemic of Heart Disease, Stroke
Guangdong Introduces New Rules for Public Hospital Drug ...
New Report Spotlights China's Visual Health Crisis
Former Chinese Pharma Executive Settles China Charges for ...
Recent Executive Moves
XiAn Janssen to Embrace A New Leader in August
Multiple Health Officials Investigated for Corruption
Recent Executive Moves
Upcoming Event: Pharma Business Development Course
Upcoming Event: Pharma Congress 2016
Upcoming Event: Pharma Business Development Course
WiCON Publishes China Pharmaceutical Guide 2016 (11th Ed...
Upcoming Event: Pharma Business Development Course
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links